Targeting chemotherapy-resistant leukemia by combining DNT cellular therapy with conventional chemotherapy
Abstract Background While conventional chemotherapy is effective at eliminating the bulk of leukemic cells, chemotherapy resistance in acute myeloid leukemia (AML) is a prevalent problem that hinders conventional therapies and contributes to disease relapse, and ultimately patient death. We have rec...
Main Authors: | Branson Chen, Jong Bok Lee, Hyeonjeong Kang, Mark D. Minden, Li Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-04-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13046-018-0756-9 |
Similar Items
-
Enhancing Therapeutic Efficacy of Double Negative T Cells against Acute Myeloid Leukemia Using Idelalisib
by: Hyeonjeong Kang, et al.
Published: (2021-10-01) -
State-of-Art of Cellular Therapy for Acute Leukemia
by: Jong-Bok Lee, et al.
Published: (2021-04-01) -
Phase I non-randomized clinical trial of allogeneic natural killer cells infusion in acute myeloid leukemia patients
by: Mohammad Ahmadvand, et al.
Published: (2023-11-01) -
Comparison of the efficacy of chemotherapy and allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in first remission in adults
by: S. N. Bondarenko, et al.
Published: (2015-09-01) -
Allogeneic stem cell transplantation in acute myeloid leukemia
by: Natasha Ali, et al.
Published: (2012-11-01)